Dear Reader, On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of treatment that can "Cut & Paste" any disease from your body. It's like this tiny biotech invented the iPhone while Big Pharma is still selling flip phones. And our research proves that anyone who gets in today could turn every 1K into 1.54M (or more)! The Big Pharma companies that have the most to lose from this new treatment are Bristol Meyers, Pfizer, Sanofi, Novartis and Teva. Sanofi has their own new drug on the market. Pfizer last month bought Array Biopharma, which we recommended.mThat leaves Novartis, Teva and Bristol Meyers. We think Bristol Meyers is the most likely buyer because their new leukemia drug recently flunked out of FDA trials. A deal could happen any day. A takeover of the company could hand investors gains of up to 31K in the next 90 days... But we would be ok if there wasn't a deal. That's because Investor's Business Daily estimates this is a 75Bn market. Yet right now, its stock price is just a tiny fraction of that size. Get the Details on This Stock Now The Latest:  | | | | | Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. Copyright © 2019. MarketHundred | 4646 Dufferin St, North York, ON M3H 5S4 | Unsubscribe Here | |
| 
没有评论:
发表评论